Aclaris Therapeutics (ACRS) Receivables - Net (2017 - 2025)
Historic Receivables - Net for Aclaris Therapeutics (ACRS) over the last 9 years, with Q2 2025 value amounting to $194000.0.
- Aclaris Therapeutics' Receivables - Net fell 7228.57% to $194000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $194000.0, marking a year-over-year decrease of 7228.57%. This contributed to the annual value of $318000.0 for FY2024, which is 671.14% up from last year.
- As of Q2 2025, Aclaris Therapeutics' Receivables - Net stood at $194000.0, which was down 7228.57% from $250000.0 recorded in Q1 2025.
- In the past 5 years, Aclaris Therapeutics' Receivables - Net ranged from a high of $939000.0 in Q2 2021 and a low of $194000.0 during Q2 2025
- In the last 5 years, Aclaris Therapeutics' Receivables - Net had a median value of $540500.0 in 2022 and averaged $526666.7.
- As far as peak fluctuations go, Aclaris Therapeutics' Receivables - Net surged by 6241.3% in 2024, and later crashed by 7228.57% in 2025.
- Over the past 5 years, Aclaris Therapeutics' Receivables - Net (Quarter) stood at $623000.0 in 2021, then dropped by 22.31% to $484000.0 in 2022, then plummeted by 38.43% to $298000.0 in 2023, then increased by 6.71% to $318000.0 in 2024, then tumbled by 38.99% to $194000.0 in 2025.
- Its Receivables - Net was $194000.0 in Q2 2025, compared to $250000.0 in Q1 2025 and $318000.0 in Q4 2024.